Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval.
Viruses. 2020 Dec 31;13(1):54. doi: 10.3390/v13010054.
Viruses. 2020.
PMID: 33396343
Free PMC article.
Review.